AI assistant
Sending…
Bio Green Med Solution, Inc. — Director's Dealing 2019
May 31, 2019
35092_dirs_2019-05-31_c0539a02-1acc-40af-b955-91d4f4cffe34.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2019-05-29
Reporting Person: Spiegel Robert J. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-29 | Stock Option (right to buy) | $0.64 | A | 18750 | Acquired | 2029-05-29 | Common Stock (18750) | Direct |
Footnotes
F1: These options were granted to Dr. Spiegel for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.
More from Bio Green Med Solution, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 13
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 12
Regulatory Filings
2025
Nov 28
Annual Report
2025
Nov 26
Director's Dealing
2025
Nov 14
Director's Dealing
2025
Nov 14
Major Shareholding Notification
2025
Nov 14
Interim / Quarterly Report
2025
Nov 13